Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 1.92
NAS:STAA's Cash to Debt is ranked higher than
53% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.56 vs. NAS:STAA: 1.92 )
Ranked among companies with meaningful Cash to Debt only.
NAS:STAA' s Cash to Debt Range Over the Past 10 Years
Min: 0.08  Med: 1.97 Max: 9.66
Current: 1.92
0.08
9.66
Equity to Asset 0.58
NAS:STAA's Equity to Asset is ranked higher than
50% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. NAS:STAA: 0.58 )
Ranked among companies with meaningful Equity to Asset only.
NAS:STAA' s Equity to Asset Range Over the Past 10 Years
Min: 0.29  Med: 0.65 Max: 0.81
Current: 0.58
0.29
0.81
F-Score: 3
Z-Score: 6.06
M-Score: -3.18
WACC vs ROIC
12.23%
-46.32%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -17.88
NAS:STAA's Operating margin (%) is ranked lower than
72% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.16 vs. NAS:STAA: -17.88 )
Ranked among companies with meaningful Operating margin (%) only.
NAS:STAA' s Operating margin (%) Range Over the Past 10 Years
Min: -27.22  Med: -8.24 Max: 4.43
Current: -17.88
-27.22
4.43
Net-margin (%) -16.00
NAS:STAA's Net-margin (%) is ranked lower than
68% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.53 vs. NAS:STAA: -16.00 )
Ranked among companies with meaningful Net-margin (%) only.
NAS:STAA' s Net-margin (%) Range Over the Past 10 Years
Min: -30.97  Med: -9.83 Max: 2.15
Current: -16
-30.97
2.15
ROE (%) -32.85
NAS:STAA's ROE (%) is ranked lower than
76% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.19 vs. NAS:STAA: -32.85 )
Ranked among companies with meaningful ROE (%) only.
NAS:STAA' s ROE (%) Range Over the Past 10 Years
Min: -88.78  Med: -19.65 Max: 5.2
Current: -32.85
-88.78
5.2
ROA (%) -20.46
NAS:STAA's ROA (%) is ranked lower than
72% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. NAS:STAA: -20.46 )
Ranked among companies with meaningful ROA (%) only.
NAS:STAA' s ROA (%) Range Over the Past 10 Years
Min: -43.45  Med: -10.93 Max: 3.01
Current: -20.46
-43.45
3.01
ROC (Joel Greenblatt) (%) -42.46
NAS:STAA's ROC (Joel Greenblatt) (%) is ranked lower than
71% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.92 vs. NAS:STAA: -42.46 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NAS:STAA' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -131.74  Med: -21.58 Max: 22.07
Current: -42.46
-131.74
22.07
Revenue Growth (3Y)(%) 3.70
NAS:STAA's Revenue Growth (3Y)(%) is ranked lower than
53% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. NAS:STAA: 3.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NAS:STAA' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -12.5  Med: -6.7 Max: 9.6
Current: 3.7
-12.5
9.6
EPS Growth (3Y)(%) 50.40
NAS:STAA's EPS Growth (3Y)(%) is ranked higher than
90% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.00 vs. NAS:STAA: 50.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
NAS:STAA' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -40.5  Med: -22.3 Max: 50.4
Current: 50.4
-40.5
50.4
» NAS:STAA's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-10-28)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

STAA Guru Trades in Q2 2015

Jim Simons Sold Out
» More
Q4 2015

STAA Guru Trades in Q4 2015

Jim Simons 14,200 sh (New)
» More
Q1 2016

STAA Guru Trades in Q1 2016

Jim Simons 150,400 sh (+959.15%)
» More
Q2 2016

STAA Guru Trades in Q2 2016

Jim Simons 162,700 sh (+8.18%)
» More
» Details

Insider Trades

Latest Guru Trades with STAA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:NAS:ENTL, NAS:LMAT, NAS:CFMS, NAS:MLAB, NAS:UNIS, NAS:OSUR, AMEX:CRHM, NAS:ATRS, OTCPK:GMDTF, NAS:UTMD, NAS:ATRC, NAS:IVTY, AMEX:LBMH, AMEX:TRXC, NAS:SIEN, NAS:DSCI, NAS:ANGO, AMEX:BVX, NAS:BIOL, NAS:HBIO » details
Traded in other countries:SR3.Germany,
Staar Surgical along with its subsidiaries designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company develops, produces, and markets intraocular lenses.

Staar Surgical along with its subsidiaries designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company develops, produces, and markets intraocular lenses. The Company was incorporated in the state of California in 1982. It was reincorporated in Delaware in 1986. The Company along with its subsidiaries designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The lenses are used in corrective or refractive surgery. The Company also makes lenses for use in surgery that treats cataracts. The Company operates as one operating segment, the ophthalmic surgical market. The Company maintains manufacturing and administrative facilities in the United States, Switzerland and Japan. The Company competes with other elective surgical procedures such as laser vision correction or LASIK, for those consumers who are looking for an alternative to eyeglasses or contact lenses to correct their vision.

Ratios

vs
industry
vs
history
Forward P/E 208.33
STAA's Forward P/E is ranked lower than
93% of the 42 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.70 vs. STAA: 208.33 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 9.83
STAA's P/B is ranked lower than
90% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.23 vs. STAA: 9.83 )
Ranked among companies with meaningful P/B only.
STAA' s P/B Range Over the Past 10 Years
Min: 1.37  Med: 7.07 Max: 17.59
Current: 9.83
1.37
17.59
P/S 4.59
STAA's P/S is ranked lower than
68% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.13 vs. STAA: 4.59 )
Ranked among companies with meaningful P/S only.
STAA' s P/S Range Over the Past 10 Years
Min: 0.34  Med: 3.44 Max: 9.89
Current: 4.59
0.34
9.89
Current Ratio 2.40
STAA's Current Ratio is ranked lower than
54% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.46 vs. STAA: 2.40 )
Ranked among companies with meaningful Current Ratio only.
STAA' s Current Ratio Range Over the Past 10 Years
Min: 1.06  Med: 2.53 Max: 3.77
Current: 2.4
1.06
3.77
Quick Ratio 1.63
STAA's Quick Ratio is ranked lower than
51% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.64 vs. STAA: 1.63 )
Ranked among companies with meaningful Quick Ratio only.
STAA' s Quick Ratio Range Over the Past 10 Years
Min: 0.55  Med: 1.49 Max: 2.37
Current: 1.63
0.55
2.37
Days Inventory 225.19
STAA's Days Inventory is ranked lower than
84% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 126.57 vs. STAA: 225.19 )
Ranked among companies with meaningful Days Inventory only.
STAA' s Days Inventory Range Over the Past 10 Years
Min: 154.29  Med: 199.21 Max: 291.16
Current: 225.19
154.29
291.16
Days Sales Outstanding 73.65
STAA's Days Sales Outstanding is ranked lower than
66% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.25 vs. STAA: 73.65 )
Ranked among companies with meaningful Days Sales Outstanding only.
STAA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 41.05  Med: 53.34 Max: 74.19
Current: 73.65
41.05
74.19
Days Payable 128.57
STAA's Days Payable is ranked higher than
85% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 48.01 vs. STAA: 128.57 )
Ranked among companies with meaningful Days Payable only.
STAA' s Days Payable Range Over the Past 10 Years
Min: 58.49  Med: 84.3 Max: 137.15
Current: 128.57
58.49
137.15

Buy Back

vs
industry
vs
history
Yield on cost (5-Year) 1.20
STAA's Yield on cost (5-Year) is ranked lower than
67% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.88 vs. STAA: 1.20 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
STAA' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 1.2
3-Year Average Share Buyback Ratio -3.10
STAA's 3-Year Average Share Buyback Ratio is ranked higher than
50% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.10 vs. STAA: -3.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
STAA' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -13.1  Med: -6 Max: -1.6
Current: -3.1
-13.1
-1.6

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 17.19
STAA's Price/Net Current Asset Value is ranked lower than
79% of the 116 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.50 vs. STAA: 17.19 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
STAA' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 2.23  Med: 12.16 Max: 45.33
Current: 17.19
2.23
45.33
Price/Tangible Book 10.55
STAA's Price/Tangible Book is ranked lower than
85% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.58 vs. STAA: 10.55 )
Ranked among companies with meaningful Price/Tangible Book only.
STAA' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.94  Med: 7.1 Max: 24.29
Current: 10.55
0.94
24.29
Price/Projected FCF 37.12
STAA's Price/Projected FCF is ranked lower than
98% of the 88 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.95 vs. STAA: 37.12 )
Ranked among companies with meaningful Price/Projected FCF only.
STAA' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.87  Med: 15 Max: 147.8
Current: 37.12
0.87
147.8
Price/Median PS Value 1.35
STAA's Price/Median PS Value is ranked lower than
63% of the 172 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.18 vs. STAA: 1.35 )
Ranked among companies with meaningful Price/Median PS Value only.
STAA' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.12  Med: 0.95 Max: 2.83
Current: 1.35
0.12
2.83
Earnings Yield (Greenblatt) (%) -3.67
STAA's Earnings Yield (Greenblatt) (%) is ranked lower than
69% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.90 vs. STAA: -3.67 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
STAA' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -3.74  Med: 0.5 Max: 0.9
Current: -3.67
-3.74
0.9

More Statistics

Revenue (TTM) (Mil) $79.85
EPS (TTM) $ -0.32
Beta1.43
Short Percentage of Float8.82%
52-Week Range $4.98 - 9.78
Shares Outstanding (Mil)40.43

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 83 88 93
EPS ($) -0.19 0.05 0.23
EPS w/o NRI ($) -0.19 0.05 0.23
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for NAS:STAA

Headlines

Articles On GuruFocus.com
Insider Trades of the Week: Facebook, Delta Air Lines May 20 2016 
Weekly CFO Sells Highlight: MHR, DISCA, BCR, STAA, PEGA, IDXX Aug 22 2011 

More From Other Websites
STAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure Sep 22 2016
STAAR Surgical Announces Approval by Health Canada of Its EVO Visian ICL™ Toric Lens Specifically... Sep 22 2016
STAAR Surgical Announces Approval by Health Canada of Its EVO Visian ICL™ Toric Lens Specifically... Sep 22 2016
STAAR Surgical Announces Strategic Cooperation Agreement With World Eye Hospital Group Sep 17 2016
STAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure Sep 15 2016
Leading Refractive Surgery Provider, EyeQ Vision Private Ltd., Gurgaon, India and STAAR Surgical... Sep 15 2016
Leading Refractive Surgery Provider, EyeQ Vision Private Ltd., Gurgaon, India and STAAR Surgical... Sep 15 2016
ETF’s with exposure to STAAR Surgical Co. : September 14, 2016 Sep 14 2016
STAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Sep 07 2016
STAAR Surgical Announces Strategic Cooperation Agreement With World Eye Hospital Group Sep 07 2016
STAAR Surgical Announces Strategic Cooperation Agreement With World Eye Hospital Group Sep 07 2016
ETF’s with exposure to STAAR Surgical Co. : August 15, 2016 Aug 15 2016
STAAR SURGICAL CO Financials Aug 11 2016
STAAR Surgical Co. :STAA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 Aug 11 2016
STAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Aug 10 2016
STAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Aug 04 2016
Staar Surgical reports 2Q loss Aug 03 2016
Staar Surgical reports 2Q loss Aug 03 2016
STAAR Surgical Co Earnings Call scheduled for 4:30 pm ET today Aug 03 2016
STAAR Surgical Reports Second Quarter 2016 Results Aug 03 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)